SCHEMBL6159475

SCHEMBL6159475

O/N=C/c1ccc(Oc2ccc(Cl)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.57
GFER P55789 2/20 0.49
MAPK1 P28482 1/20 0.49
KMT2A Q03164 3/20 0.49
MAPT P10636 2/20 0.49
ALDH1A1 P00352 2/20 0.49
MEN1 O00255 2/20 0.49
FURIN P09958 1/20 0.47
MAOB P27338 2/20 0.47
MAOA P21397 1/20 0.47
GAA P10253 1/20 0.45
RAB9A P51151 4/20 0.45
NPC1 O15118 3/20 0.45
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44
GRIN2D O15399 2/20 0.44
GRIN3B O60391 2/20 0.44
GRIN1 Q05586 2/20 0.44
GRIN2A Q12879 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6159479 1.00 HTT (0.57) HTTGFERMAPK1KMT2AMAPT
SCHEMBL16945360 1.00 HTT (0.57) HTTGFERMAPK1KMT2AMAPT
SCHEMBL1505540 0.87 MAOB (0.58) HTTMAPK1KMT2AMAPTALDH1A1
SCHEMBL2161959 0.87 MAOB (0.58) HTTMAPK1KMT2AMAPTALDH1A1
SCHEMBL1505539 0.87 MAOB (0.58) HTTMAPK1KMT2AMAPTALDH1A1
Hydrochloric Acid SCHEMBL27732134 0.85 MAOB (0.56) HTTMAPK1KMT2AMAPTALDH1A1
SCHEMBL9219952 0.83 ALDH1A1 (0.62) HTTKMT2AMAPTALDH1A1MEN1
SCHEMBL9219950 0.83 ALDH1A1 (0.62) HTTKMT2AMAPTALDH1A1MEN1
SCHEMBL16945357 0.82 RAB9A (0.59) HTTGFERMAPK1KMT2AMAPT
SCHEMBL5957960 0.82 RAB9A (0.59) HTTGFERMAPK1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2875029-B1 5,5-HETEROAROMATIC ANTI-INFECTIVE COMPOUNDS MORASKI GARRETT (US) 2021-11-10 EP disclosed
US-9670192-B2 Substituted isoxazole derivatives BASF SE (DE) 2017-06-06 US disclosed
US-9605002-B2 5,5-heteroaromatic anti-infective compounds UNIVERSITY OF NOTRE DAME DU LAC (US) 2017-03-28 US disclosed
EP-2997026-B1 SUBSTITUTED ISOXAZOLE DERIVATIVES BASF SE (DE) 2017-03-15 EP disclosed
US-20160096829-A1 Substituted Isoxazole Derivatives BASF SE (DE) 2016-04-07 US disclosed
US-20150210715-A1 5,5-HETEROAROMATIC ANTI-INFECTIVE COMPOUNDS UNIVERSITY OF NOTRE DAME DU LAC 2015-07-30 US disclosed
EP-2875029-A2 5,5-HETEROAROMATIC ANTI-INFECTIVE COMPOUNDS Moraski, Garrett (US) 2015-05-27 EP disclosed
WO-2014015167-A2 5,5-HETEROAROMATIC ANTI-INFECTIVE COMPOUNDS UNIVERSITY OF NOTRE DAME DU LAC (US) 2014-01-23 WO disclosed
US-6953789-B2 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-10-11 US disclosed
US-20040157894-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-08-12 US disclosed
US-6699881-B2 MATRIX METALLOPROTEASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2004-03-02 US disclosed
US-20030078253-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY, LIMITED (JP) 2003-04-24 US disclosed
US-6420415-B1 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-07-16 US disclosed
EP-1132379-A1 NOVEL THIOL DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF Takeda Chemical Industries, Ltd. (JP) 2001-09-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078253-A1 Thiol compounds, their production and use TST, QSOX1, SULT1E1 HTT 1420/4885GFER 103/4885MAPK1 2637/4885
US-20040157894-A1 Thiol compounds, their production and use TST, SULT1E1, QSOX1 HTT 1459/4885GFER 133/4885MAPK1 2685/4885
US-20160096829-A1 Substituted Isoxazole Derivatives COX4I1, CYP4X1, TBXA2R HTT 2881/4885GFER 2149/4885MAPK1 3779/4885
US-20150210715-A1 5,5-HETEROAROMATIC ANTI-INFECTIVE COMPOUNDS API5, CASP5, IL5 HTT 3043/4885GFER 2607/4885MAPK1 3237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.